EDAP TMS

Related by string. * EDAPS : http:/www.edap-tms.com http:/www.hifu-planet.comdilutionary effect . http:/www.edap-tms.com . Nasdaq EDAP . NASDAQ EDAP . Marc Oczachowski EDAP / Tm . TMD . TMs . tm : FinancialWire tm website . Forrester Wave TM . TM EA SPORTS . Contact FinancialWire tm * EDAP TMS SA . PRNewswire FirstCall EDAP TMS . GLOBE NEWSWIRE EDAP TMS . CONTACT EDAP TMS *

Related by context. Frequent words. (Click for all words.) 63 Lifts FY# Outlook 61 Æterna Zentaris 61 Nasdaq ADLR 61 Arthur S. Przybyl 60 Forecast Quick Facts 60 www.delcath.com 59 Kiadis Pharma 59 www.labopharm.com 59 Preliminary Third Quarter 59 Jumps Higher 59 Q2 Loss Narrows 59 Q3 Loss Narrows 58 SciClone Pharmaceuticals 58 Guides FY# 58 Patient Enrollment 58 ALTANA AG 58 Inovio Pharmaceuticals 58 Walt Woltosz chairman 58 Q4 Loss Narrows 58 ISTA Pharmaceuticals 58 Q1 Loss Narrows 57 Preliminary Second Quarter 57 Q2 Loss Widens 57 Guides Inline 57 Q3 Loss Widens 57 AEterna 57 LGL Group 57 NASDAQ IPXL today 57 Guides Q2 56 Webcast Presentations 56 Guides Q4 56 Ampio 56 www.spectrumpharm.com 56 Advanced Magnetics 56 Keryx Biopharmaceuticals 56 Q4 Loss Widens 56 http:/www.nabi.com 56 THALOMID 56 Provides Shareholder 56 Q1 Loss Widens 56 Larry W. Reaugh 56 Earnings Postmortem 56 Q2 Profit Surges 55 Simon Sturge 55 Guides Q1 55 Hold Fourth Quarter 55 NYSE MRX 55 Welcomes Analyst Initiation 55 XLTEK 55 Two Investor Conferences 55 Above Consensus 55 Updates Guidance 55 WILEX 55 Clayton Hardman 55 Record Third Quarter 55 Q3 Profit Surges 54 Opexa 54 MERLIN TIMI 54 Lifts FY# EPS 54 SCOLR Pharma 54 Rebif ® 54 Q1 Profit Surges 54 Q4 Profit Surges 54 Discusses Q3 54 ESBATech 54 Posts Narrower Loss 54 Penwest Pharmaceuticals 54 Dominique Doucet 54 Aegerion 54 Intellipharmaceutics 54 Announces FDA Clearance 54 Tops Estimate 54 Above Estimates 54 LD Micro 54 Brian JG Pereira 54 Aegera 54 Discusses Q4 54 Files Shelf Registration Statement 54 NASDAQ DYAX 54 Alain Dutheil 53 Hold Third Quarter 53 BMP Sunstone Corporation 53 Lowers Guidance 53 Upcoming Investor Conference 53 Preliminary Fourth Quarter 53 Dino Dina 53 Record Fourth Quarter 53 Receives Orphan Drug Designation 53 visit www.scansourceinc.com 53 Reports Profitable 53 Enrolls First 53 ImmunoCellular Therapeutics 53 ANAVEX 53 Analyst Upgrade 53 Novadaq Technologies Inc. 53 www.syneron.com 53 Azilect ® 53 Gilles Gagnon 53 Lung Rx 53 widens Quick Facts 53 Strengthens Leadership

Back to home page